Table 3 Cardiovascular related readmissions and number of deceased patients during 1 year after index event in patients admitted with a type 1 myocardial infarction at the coronary care unit to Helsingborg’s hospital between 1 January 2011 and 1 January 2015 and discharged without a β-blocker prescription, compared to patients admitted with a type 1 myocardial infarction at the coronary care unit to Helsingborg’s hospital between 1 January 2013 and 31 December 2013 and discharged with a β-blocker prescription. First readmission counted only. TIA = Transient ischemic attack
From: β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
No-β-group n = 141 (Mean (%) | β-group n = 206 (Mean (%) | p-value | |
|---|---|---|---|
Readmission for myocardial infarction | 8 (5.7%) | 2 (1.0%) | 0.02 |
Readmission for myocardial infarction, angina pectoris or heart failure | 20 (14.2%) | 17 (8.3%) | 0.11 |
Readmission for myocardial infarction, angina pectoris, heart failure, arrhythmia, stroke or TIA | 23 (16.3%) | 25 (12.1%) | 0.27 |
All cause death | 6 (4.3%) | 2 (1.0%) | 0.07 |
Cardiovascular related death | 1 (0.7%) | 1 (0.5%) | > 0.99 |